7-5721061-T-A
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBS1_Supporting
The NM_207111.4(RNF216):c.1616A>T(p.Tyr539Phe) variant causes a missense change. The variant allele was found at a frequency of 0.0000805 in 1,614,242 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Y539C) has been classified as Uncertain significance.
Frequency
Consequence
NM_207111.4 missense
Scores
Clinical Significance
Conservation
Publications
- cerebellar ataxia-hypogonadism syndromeInheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -5 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| RNF216 | NM_207111.4 | c.1616A>T | p.Tyr539Phe | missense_variant | Exon 9 of 17 | ENST00000389902.8 | NP_996994.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| RNF216 | ENST00000389902.8 | c.1616A>T | p.Tyr539Phe | missense_variant | Exon 9 of 17 | 1 | NM_207111.4 | ENSP00000374552.3 | ||
| RNF216 | ENST00000425013.6 | c.1445A>T | p.Tyr482Phe | missense_variant | Exon 9 of 17 | 1 | ENSP00000404602.2 | |||
| RNF216 | ENST00000389900.8 | n.*733A>T | non_coding_transcript_exon_variant | Exon 8 of 16 | 1 | ENSP00000374550.4 | ||||
| RNF216 | ENST00000389900.8 | n.*733A>T | 3_prime_UTR_variant | Exon 8 of 16 | 1 | ENSP00000374550.4 |
Frequencies
GnomAD3 genomes AF: 0.000420 AC: 64AN: 152240Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000119 AC: 30AN: 251480 AF XY: 0.0000809 show subpopulations
GnomAD4 exome AF: 0.0000451 AC: 66AN: 1461884Hom.: 0 Cov.: 31 AF XY: 0.0000330 AC XY: 24AN XY: 727240 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000420 AC: 64AN: 152358Hom.: 0 Cov.: 32 AF XY: 0.000456 AC XY: 34AN XY: 74498 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This sequence change replaces tyrosine, which is neutral and polar, with phenylalanine, which is neutral and non-polar, at codon 539 of the RNF216 protein (p.Tyr539Phe). This variant is present in population databases (rs148642312, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with RNF216-related conditions. ClinVar contains an entry for this variant (Variation ID: 1409677). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at